FDA announces launch of Project FrontRunner

Earlier this year, the FDA announced plans to launch Project FrontRunner to support manufacturers in prioritizing the development of cancer drugs in early treatment lines, partly in response to issues that have arisen with the current accelerated approval scheme. In this #Access90 video, Precision’s Dominika Meszarosova discusses the issues that Project Frontrunner seeks to address and the critical need for early dialogue, incentives and close collaboration with manufacturers to ensure success. Watch the full video here!